tiprankstipranks
Advertisement
Advertisement

INO Stock Latest News

Inovio Pharmaceuticals Announces New Public Equity Offering
Company AnnouncementsInovio Pharmaceuticals Announces New Public Equity Offering
4d ago
8K
INO
Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program
PremiumCompany Announcements
Inovio Pharmaceuticals Suspends Existing At-the-Market Stock Program
8d ago
8K
INO
Inovio files to sell common stock, no amount given
PremiumThe Fly
Inovio files to sell common stock, no amount given
9d ago
INO
Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
PremiumMarket News
Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
18d ago
INO
Inovio’s Earnings Call: INO-3107 Drives 2026 Focus
PremiumCompany Announcements
Inovio’s Earnings Call: INO-3107 Drives 2026 Focus
24d ago
INO
Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
PremiumRatingsInovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
25d ago
INO
Inovio reports Q4 EPS (26c), consensus (34c)
Premium
The Fly
Inovio reports Q4 EPS (26c), consensus (34c)
29d ago
INO
Options Volatility and Implied Earnings Moves Today, March 12, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 12, 2026
29d ago
S
DG
Inovio, Akeso announce clinical collaboration
PremiumThe Fly
Inovio, Akeso announce clinical collaboration
1M ago
INO
Inovio’s INO-3107 Timeline Under Scrutiny After Accelerated Approval Setback
PremiumClass Action
Inovio’s INO-3107 Timeline Under Scrutiny After Accelerated Approval Setback
1M ago
INO
INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
INO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
INO
Inovio Pharmaceuticals Faces Investor Lawsuit After FDA Review Setback and Stock Drop
PremiumClass Action
Inovio Pharmaceuticals Faces Investor Lawsuit After FDA Review Setback and Stock Drop
1M ago
INO
LEVI & KORSINSKY, LLP: CELLECTRA DEVICE MANUFACTURING PRACTICES AT CENTER OF INOVIO PHARMACEUTICALS SECURITIES LITIGATION
PremiumClass ActionLEVI & KORSINSKY, LLP: CELLECTRA DEVICE MANUFACTURING PRACTICES AT CENTER OF INOVIO PHARMACEUTICALS SECURITIES LITIGATION
1M ago
INO
Inovio Extends Series A Warrants, Enhancing Capital Flexibility
Premium
Company Announcements
Inovio Extends Series A Warrants, Enhancing Capital Flexibility
2M ago
8K
INO
Balanced View on INOVIO’s INO-3107: Strong Long-Term Data Offset by Regulatory and Timing Uncertainty Driving Hold Rating
Premium
Ratings
Balanced View on INOVIO’s INO-3107: Strong Long-Term Data Offset by Regulatory and Timing Uncertainty Driving Hold Rating
3M ago
INO
FDA Accepts Inovio’s BLA for INO-3107 Review
PremiumCompany Announcements
FDA Accepts Inovio’s BLA for INO-3107 Review
3M ago
8K
INO
Inovio announces U.S. FDA accepted BLA for INO-3107
PremiumThe Fly
Inovio announces U.S. FDA accepted BLA for INO-3107
3M ago
INO
Inovio Pharmaceuticals: Hold Rating Amid Financial Challenges and Pending Regulatory Milestones
PremiumRatings
Inovio Pharmaceuticals: Hold Rating Amid Financial Challenges and Pending Regulatory Milestones
5M ago
INO
Inovio price target raised to $6 from $5 at Piper Sandler
PremiumThe Fly
Inovio price target raised to $6 from $5 at Piper Sandler
5M ago
INO
Inovio Pharmaceuticals Announces Public Offering Agreement
PremiumCompany AnnouncementsInovio Pharmaceuticals Announces Public Offering Agreement
5M ago
8K
INO
Inovio Pharmaceuticals’ Earnings Call: Milestones Amid Financial Challenges
Premium
Company Announcements
Inovio Pharmaceuticals’ Earnings Call: Milestones Amid Financial Challenges
5M ago
INO
Inovio 13.16M share Spot Secondary priced at $1.90
Premium
The Fly
Inovio 13.16M share Spot Secondary priced at $1.90
5M ago
INO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >